| abstract |
The present invention relates to compounds of formula (I) and enantiomers, diastereomers and pharmaceutically acceptable salts thereof:n n n <Formula I>n n n n n n n n Compounds of formula (I) are protein kinase inhibitors and are useful for the treatment of proliferative diseases such as cancer, inflammation and arthritis. They may also be useful in the treatment of Alzheimer's disease, chemotherapy-induced alopecia, and cardiovascular disease. |